[Federal Register Volume 66, Number 85 (Wednesday, May 2, 2001)]
[Notices]
[Page 21987]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 01-10936]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Clinical Laboratory Improvement Advisory Committee (CLIAC): 
Meeting

    In accordance with section 10(a)(2) of the Federal Advisory 
Committee Act (Public Law 92-463), the Centers for Disease Control and 
Prevention (CDC) announces the following committee meeting.
    Name: Clinical Laboratory Improvement Advisory Committee (CLIAC).
    Times and Dates: 8:30 a.m.--5 p.m., May 30, 2001; 8:30 a.m.--3:30 
p.m., May 31, 2001.
    Place: CDC, Koger Center, Williams Building, Conference Rooms 1802 
and 1805, 2877 Brandywine Road, Atlanta, Georgia 30341.
    Status: Open to the public, limited only by the space available. 
The meeting room accommodates approximately 100 people.
    Purpose: This committee is charged with providing scientific and 
technical advice and guidance to the Secretary of Health and Human 
Services, the Acting Assistant Secretary for Health, and the Director, 
CDC, regarding the need for, and the nature of, revisions to the 
standards under which clinical laboratories are regulated; the impact 
on medical and laboratory practices of proposed revisions to the 
standards; and the modification of the standards to accommodate 
technological advances.
    Matters to Be Discussed: The agenda will include the waiver 
workgroup report on criteria for waiver approval and updates from CDC, 
Food and Drug Administration and Health Care Financing Administration.
    Agenda items are subject to change as priorities dictate.

CONTACT PERSON FOR ADDITIONAL INFORMATION: Rhonda Whalen, Chief, 
Laboratory Practice Standards Branch, Division of Laboratory Systems, 
Public Health Practice Program Office, CDC, 4770 Buford Highway, NE, m/
s F-11, Atlanta, Georgia 30341-3724, telephone 770/488-8042, fax 770/
488-8279.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register Notices pertaining to 
announcements of meetings and other committee management activities, 
for both the Centers for Disease Control and Prevention and the Agency 
for Toxic Substances and Disease Registry.

    Dated: April 26, 2001.
John Burckhardt,
Acting Director, Management Analysis and Services Office, Centers for 
Disease Control and Prevention.
[FR Doc. 01-10936 Filed 5-1-01; 8:45 am]
BILLING CODE 4163-01-P